Broadens the Treatable Patient Population
Includes both primary and secondary mitral regurgitation patients who are high risk for open-heart surgery
Positioned above the native mitral valve, atrial-only fixation ensures critical cardiac structures are retained within the left ventricle
AltaValve was engineered to minimize complications sometimes found with other TMVR technologies such as device embolization, left ventricular outflow tract (LVOT) obstruction, left ventricular dysfunction (e.g. chordae tendineae rupture), etc.
AltaValve’s stent enables future left atrial access for other procedures
AltaValve is the only device designed to treat patients with previous valve repair
CAUTION -- Investigational device. Limited by Federal (or United States) law to investigational use.
Specifically Designed for Streamlined Transseptal Delivery
AltaValve is recapturable even after complete deployment, leading to improved procedural safety*
The prosthetic valve is fully functional seconds after deployment, ensuring patient’s hemodynamic stability
TS Delivery System provides controlled steerability, accommodating a variety of anatomies